Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Bruce RD.

Int J Drug Policy. 2010 Mar;21(2):122-4. doi: 10.1016/j.drugpo.2009.10.004.

2.

Islam and harm reduction.

Kamarulzaman A, Saifuddeen SM.

Int J Drug Policy. 2010 Mar;21(2):115-8. doi: 10.1016/j.drugpo.2009.11.003. Epub 2009 Dec 16.

PMID:
20006483
3.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA.

Addiction. 2005 Feb;100(2):150-8. Review.

PMID:
15679744
4.

Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier.

Maguet O, Majeed M.

Int J Drug Policy. 2010 Mar;21(2):119-21. doi: 10.1016/j.drugpo.2010.01.006. Epub 2010 Feb 19.

PMID:
20171864
5.

How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.

Bergenstrom A, McLeod R, Sharma M, Mesquita F, Dorabjee J, Atun R, Lewis G, Rao JV.

Int J Drug Policy. 2010 Mar;21(2):107-9. doi: 10.1016/j.drugpo.2009.11.004. Epub 2010 Feb 9.

PMID:
20144859
6.

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG.

J Adv Nurs. 2001 Feb;33(3):357-70. Review.

PMID:
11251723
7.

Young people and drugs: next generation of harm reduction.

Merkinaite S, Grund JP, Frimpong A.

Int J Drug Policy. 2010 Mar;21(2):112-4. doi: 10.1016/j.drugpo.2009.11.006. Epub 2009 Dec 29.

PMID:
20036526
8.

Moving from a project to programmatic response: scaling up harm reduction in Asia.

Chatterjee A, Sharma M.

Int J Drug Policy. 2010 Mar;21(2):134-6. doi: 10.1016/j.drugpo.2009.12.004. Epub 2010 Jan 15.

PMID:
20079618
9.

How Ukraine is tackling Europe's worst HIV epidemic.

Hurley R.

BMJ. 2010 Jul 13;341:c3538. doi: 10.1136/bmj.c3538. No abstract available.

PMID:
20627980
11.

Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.

Wiessing L, Likatavicius G, Klempová D, Hedrich D, Nardone A, Griffiths P.

Am J Public Health. 2009 Jun;99(6):1049-52. doi: 10.2105/AJPH.2008.141846. Epub 2009 Apr 16.

12.

Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Torrens M, Fonseca F, Castillo C, Domingo-Salvany A.

Bull World Health Organ. 2013 Feb 1;91(2):136-41. doi: 10.2471/BLT.12.111054.

13.

[Prevention of HIV in injecting drug addicts. What has been done - what could be better?].

Gölz J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Apr;50(4):465-70. Review. German.

PMID:
17377723
14.

HIV among drug users in China.

Feng C, Des Jarlais D.

Science. 2002 Nov 8;298(5596):1171; author reply 1171. No abstract available.

PMID:
12425324
15.

Select barriers to harm-reduction services for IDUs in eastern Europe.

Curth NK, Hansson LN, Storm F, Lazarus JV.

Cent Eur J Public Health. 2009 Dec;17(4):191-7.

16.
17.

HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.

Navadeh S, Mirzazadeh A, Gouya MM, Farnia M, Alasvand R, Haghdoost AA.

Sex Transm Infect. 2013 Nov;89 Suppl 3:iii33-6. doi: 10.1136/sextrans-2013-051295. Epub 2013 Aug 28.

18.

The trajectory of methadone maintenance treatment in Nepal.

Ambekar A, Rao R, Pun A, Kumar S, Kishore K.

Int J Drug Policy. 2013 Nov;24(6):e57-60. doi: 10.1016/j.drugpo.2013.06.001. Epub 2013 Jul 8.

PMID:
23845916
19.

The Global Fund's leadership on harm reduction: 2002-2009.

Atun R, Kazatchkine M.

Int J Drug Policy. 2010 Mar;21(2):103-6. doi: 10.1016/j.drugpo.2010.01.002. Epub 2010 Feb 19.

PMID:
20171865

Supplemental Content

Support Center